Related Experiment Video
Updated: May 11, 2026
07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Neu2000 potentiates a kainate response in mouse cortical neurons
1Department of Brain and Cognitive Sciences, Ewha Womans University, Seoul, Korea.
Journal of Pharmacological Sciences
|May 24, 2013
Summary
Neu2000, an antioxidant and N-methyl-d-aspartate receptor antagonist, enhances kainate receptor activity. This neuroprotective compound increases the open probability of kainate receptor channels, offering novel therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Neu2000 exhibits antioxidant and N-methyl-d-aspartate receptor antagonist properties.
- It provides significant protection against ischemic damage in rodent models.
Purpose of the Study:
- To investigate the effect of Neu2000 on kainate (KA) receptor activity.
- To elucidate the mechanism by which Neu2000 modulates KA receptors.
Main Methods:
- Electrophysiological recordings were used to measure KA-evoked responses in the presence of Neu2000.
- The study examined the non-competitive and voltage-independent nature of Neu2000's interaction with KA receptors.
Main Results:
- Neu2000 significantly potentiated KA-evoked responses.
- The potentiation was non-competitive, reversible, and voltage-independent.
- Neu2000 primarily acts by increasing the open probability of KA receptor channels.
Conclusions:
- Neu2000 enhances kainate receptor function through a novel mechanism.
- This modulation of KA receptors may contribute to Neu2000's neuroprotective effects.
- Neu2000 represents a promising therapeutic agent targeting excitotoxicity.
